Bruno Lucidi Atea Pharmaceuticals, Inc. (AVIR) insider trading activity
Bruno Lucidi is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 112,750 shares of AVIR, which is worth approximately $386,732. The most recent transaction as insider was on Jun 20, 2025, when has been sold 29,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
113K
35.6%
3M change
35.6%
12M change
Total Value Held
$386,732
BL
Bruno Lucidi
Boston, MA